Business Standard

Trident Texofab standalone net profit rises 87.50% in the December 2021 quarter

Image

Capital Market

Sales rise 70.85% to Rs 23.85 crore

Net profit of Trident Texofab rose 87.50% to Rs 0.15 crore in the quarter ended December 2021 as against Rs 0.08 crore during the previous quarter ended December 2020. Sales rose 70.85% to Rs 23.85 crore in the quarter ended December 2021 as against Rs 13.96 crore during the previous quarter ended December 2020. ParticularsQuarter EndedDec. 2021Dec. 2020% Var.Sales23.8513.96 71 OPM %6.756.09 -PBDT0.970.32 203 PBT0.580.11 427 NP0.150.08 88

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 20 2022 | 8:11 AM IST

Explore News